Elevation Oncology to Participate in Upcoming Investor Conferences
Elevation Oncology (Nasdaq: ELEV), an innovative oncology company focused on developing selective cancer therapies for patients with solid tumors and significant unmet medical needs, has announced its participation in two upcoming investor conferences in March 2025.
The company will participate in:
- The TD Cowen 45th Annual Health Care Conference with a fireside chat on Tuesday, March 4, 2025 at 9:10 AM ET in Boston, MA
- The Leerink Global Biopharma Conference with a fireside chat on Tuesday, March 11, 2025 at 8:40 AM ET in Miami, FL
Live webcasts and replays of both fireside chats will be available on the Events page of Elevation Oncology's Investor Relations website at https://investors.elevationoncology.com.
Elevation Oncology (Nasdaq: ELEV), un'azienda innovativa nel settore oncologico focalizzata sullo sviluppo di terapie selettive per il cancro per pazienti con tumori solidi e significative esigenze mediche non soddisfatte, ha annunciato la sua partecipazione a due prossimi conferenze per investitori a marzo 2025.
L'azienda parteciperà a:
- La 45ª Conferenza Annuale sulla Salute di TD Cowen con una discussione informale martedì 4 marzo 2025 alle 9:10 AM ET a Boston, MA
- La Conferenza Globale sulla Biopharma di Leerink con una discussione informale martedì 11 marzo 2025 alle 8:40 AM ET a Miami, FL
Le dirette web e le registrazioni delle due discussioni informali saranno disponibili nella pagina Eventi del sito web delle Relazioni con gli Investitori di Elevation Oncology all'indirizzo https://investors.elevationoncology.com.
Elevation Oncology (Nasdaq: ELEV), una empresa innovadora en oncología centrada en desarrollar terapias selectivas contra el cáncer para pacientes con tumores sólidos y necesidades médicas no satisfechas, ha anunciado su participación en dos próximas conferencias para inversores en marzo de 2025.
La empresa participará en:
- La 45ª Conferencia Anual de Salud de TD Cowen con una charla junto a la chimenea el martes 4 de marzo de 2025 a las 9:10 AM ET en Boston, MA
- La Conferencia Global de Biopharma de Leerink con una charla junto a la chimenea el martes 11 de marzo de 2025 a las 8:40 AM ET en Miami, FL
Las transmisiones en vivo y las repeticiones de ambas charlas estarán disponibles en la página de Eventos del sitio web de Relaciones con Inversores de Elevation Oncology en https://investors.elevationoncology.com.
Elevation Oncology (Nasdaq: ELEV)는 고형 종양과 중요한 의학적 요구가 충족되지 않은 환자를 위한 선택적 암 치료법 개발에 집중하는 혁신적인 온콜로지 회사로, 2025년 3월에 예정된 두 개의 투자자 회의에 참여한다고 발표했습니다.
회사는 다음에 참여할 예정입니다:
- TD Cowen 제45회 연례 의료 회의에서 화요일, 2025년 3월 4일 오전 9시 10분 ET에 보스턴, MA에서 대담을 진행합니다.
- Leerink 글로벌 바이오파마 회의에서 화요일, 2025년 3월 11일 오전 8시 40분 ET에 마이애미, FL에서 대담을 진행합니다.
두 대담의 생중계 및 녹화는 Elevation Oncology의 투자자 관계 웹사이트의 이벤트 페이지에서 확인할 수 있습니다: https://investors.elevationoncology.com.
Elevation Oncology (Nasdaq: ELEV), une entreprise innovante en oncologie axée sur le développement de thérapies anticancéreuses sélectives pour les patients atteints de tumeurs solides et ayant des besoins médicaux non satisfaits, a annoncé sa participation à deux prochaines conférences pour investisseurs en mars 2025.
L'entreprise participera à :
- La 45e Conférence Annuelle sur la Santé de TD Cowen avec une discussion informelle le mardi 4 mars 2025 à 9h10 ET à Boston, MA
- La Conférence Mondiale Biopharma de Leerink avec une discussion informelle le mardi 11 mars 2025 à 8h40 ET à Miami, FL
Les diffusions en direct et les rediffusions des deux discussions seront disponibles sur la page Événements du site Web des Relations avec les Investisseurs d'Elevation Oncology à l'adresse https://investors.elevationoncology.com.
Elevation Oncology (Nasdaq: ELEV), ein innovatives Onkologieunternehmen, das sich auf die Entwicklung selektiver Krebstherapien für Patienten mit soliden Tumoren und erheblichen unerfüllten medizinischen Bedürfnissen konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im März 2025 angekündigt.
Das Unternehmen wird an folgenden Veranstaltungen teilnehmen:
- Der 45. jährlichen Gesundheitskonferenz von TD Cowen mit einem Gespräch am Feuer am Dienstag, den 4. März 2025 um 9:10 Uhr ET in Boston, MA
- Der Leerink Global Biopharma Konferenz mit einem Gespräch am Feuer am Dienstag, den 11. März 2025 um 8:40 Uhr ET in Miami, FL
Live-Webcasts und Wiederholungen beider Gespräche werden auf der Veranstaltungsseite der Investor-Relations-Website von Elevation Oncology unter https://investors.elevationoncology.com verfügbar sein.
- None.
- None.
- TD Cowen 45th Annual Health Care Conference. Fireside chat on Tuesday, March 4, 2025 at 9:10 AM ET in
Boston, MA. - Leerink Global Biopharma Conference. Fireside chat on Tuesday, March 11, 2025 at 8:40 AM ET in
Miami, FL.
A live webcast and replay of the fireside chats will be available on the Events page of the Company's Investor Relations website at https://investors.elevationoncology.com.
About Elevation Oncology, Inc.
Elevation Oncology is an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. We are leveraging our ADC expertise to advance a novel pipeline, initially targeting two clinically validated targets in oncology, Claudin 18.2 and HER3. Our lead candidate, EO-3021, is a potential best-in-class, Claudin 18.2 ADC and is currently being evaluated in a Phase 1 trial (NCT05980416) as a monotherapy, and in combinations with dostarlimab or ramucirumab, in patients with advanced, unresectable or metastatic gastric/gastroesophageal adenocarcinoma that express Claudin 18.2. We are also advancing EO-1022, a HER3 ADC for the treatment of patients living with solid tumors that express HER3, through preclinical development. For more information, visit www.ElevationOncology.com.
Elevation Oncology Investor and Media Contact
Gracie Tong
Senior Director, Investor Relations and Corporate Communications
gtong@elevationoncology.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/elevation-oncology-to-participate-in-upcoming-investor-conferences-302382527.html
SOURCE Elevation Oncology
FAQ
When will Elevation Oncology (ELEV) present at the TD Cowen Health Care Conference in 2025?
What investor conferences is Elevation Oncology (ELEV) attending in March 2025?
Where can investors watch Elevation Oncology's (ELEV) March 2025 conference presentations?
What is Elevation Oncology's (ELEV) focus in cancer treatment development?
When is Elevation Oncology (ELEV) presenting at the Leerink Global Biopharma Conference?
